Task: Answer the MCQ question.
Question: Which drug exhibits a -58.537% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. Cc1ccc(C(CC(=O)NCc2ccco2)c2ccc(OC(C)C)cc2)cc1
b. Cc1ccc(C(=O)Nc2nnc(S(=O)(=O)N3CCCCCC3)s2)cc1
c. Cc1cc(Nc2ccccc2)c2c([N+](=O)[O-])cc(C)c(C)c2n1
d. COc1cc([N+](=O)[O-])ccc1NC(=O)c1cccc(NC(=O)C(C)C)c1
e. CC(C)CCNc1nc(N2CCCC2)c2c(c1C#N)CCN(C)C2
Answer: e. CC(C)CCNc1nc(N2CCCC2)c2c(c1C#N)CCN(C)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CCNc1nc(N2CCCC2)c2c(c1C#N)CCN(C)C2
CC(C)CCNc1nc(N2CCCC2)c2c(c1C#N)CCN(C)C2
7-methyl-3-(3-methylbutylamino)-1-pyrrolidin-1-yl-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile